News: Pharma
Home News: Pharma
Pharmaceutical Industry News, Drugs, Nutraceuticals, Vitamins, and Related
Jury Awards $9B to a New York man who developed bladder cancer after taking Actos
NEW YORK CITY, N.Y. /eNewsChannels/ -- NEWS: Actos manufacturer Takeda and its partner Eli Lilly were hit this week with a $9 Billion verdict over the safety of their popular diabetes drug. After a two month trial, the jury found that Weitz and Luxenberg client Terrence Allen's use of Actos caused bladder cancer and the drug manufacturer and marketer failed to warn of this life-threatening risk.
Paragon BioTeck, Inc. receives FDA Approval for Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent
PORTLAND, Ore. /eNewsChannels/ -- NEWS: Paragon BioTeck, Inc., a privately held biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, received FDA approval of Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent, to dilate the pupil on March 21, 2013.
SignatureCLL SignatuRx Test for Patients with Chronic Lymphocytic Leukemia Shown to Reduce Early Cancer Deaths
HUNTINGTON BEACH, Calif. /eNewsChannels/ -- NEWS: SignatureCLL today announced that the first laboratory test ever shown in a clinical trial to improve one year survival rates in cancer is now available to patients with chronic lymphocytic leukemia (CLL). The U.S. cancer physician who invented the test and the British scientist who used it to make discoveries in leukemia will offer the test under the trade name SignatuRx through their own, newly-formed laboratory company.
Paragon BioTeck to launch new line of eyecare products at the Annual American Academy of Ophthalmology meeting
PORTLAND, Ore. /eNewsChannels/ -- NEWS: Biopharmaceutical company Paragon BioTeck, Inc. today announced that it plans to launch its new line of products, known as Ilast(R), at the Annual American Academy of Ophthalmology meeting in New Orleans. Paragon signed an exclusive distribution agreement with Horus Pharma to supply Ilast(R) ocular care products in the U.S. last month, and the company is excited to release these products to ophthalmology professionals.
Dr. Rick Lentini of Nutronics Labs explains what makes a reputable deer antler spray company
CHICAGO, Ill. /eNewsChannels/ -- NEWS: Nutronics Labs, a Natural supplement company, today released a statement encouraging deer antler spray consumers to do thorough product research before buying health supplements online. Nutronics Labs is the leading manufacturer of deer antler spray and boasts the world's strongest supplements available.
Paragon BioTeck Inc to Distribute Horus Pharma Ilast Ocular Hygiene in U.S. with Exclusive Agreement
PORTLAND, Ore. /eNewsChannels/ -- NEWS: Paragon BioTeck, Inc. signs a distribution agreement with Horus Pharma for rights to supply the Ilast range of its medical-grade ocular hygiene and lid care products within the United States. It begins on an exclusive basis this month.
Paragon BioTeck and Bausch + Lomb sign Exclusive License Agreement for Phenylephrine
MADISON, N.J. /eNewsChannels/ -- NEWS Apr 19, 2013: Bausch + Lomb, the global eye health company and Paragon BioTeck, Inc. today announced that the companies have entered into a license agreement for Bausch + Lomb to commercialize and distribute Paragon's phenylephrine in the United States on an exclusive basis beginning this month.
RXCut Plus announces new website designed to help people get the best prescription drug prices
DOVER, Pa. /eNewsChannels/ -- RXCut(R) Plus announced this week a new website that is designed to help people get the best prescription price available. 'Our cutting-edge pharmacy price search is tightly integrated with Google Maps technology making it faster and easier for people to access pharmacy information,' Gerard Ferro, founder and CEO RXCut(R) Plus, says.
New products featured in Laboratory Supply Distributors' latest catalog serve chromatography, biotechnology, pharma markets
MILLVILLE, N.J. /eNewsChannels/ -- Laboratory Supply Distributors Corp., a provider of diverse products for the chromatography, biotechnology, pharmaceutical and environmental industries, today announced the launch of its 2013 catalog. It showcases many new products for the life science and biotech markets.
Make 2013 a Year Without Head Lice!
BRIDGEPORT, Conn. (SEND2PRESS NEWSWIRE) — Head lice love the holidays as much as kids do, says George Coleman, founder of Dermedics Laboratories and master-mind behind the only non-toxic, FDA registered head lice treatment and repellent used by the U.S. Department of Health and Human Services to treat and prevent head lice infestations. Holiday parties give [...]